1. | shastaflower66 | |
2. | jimneal | |
3. | nevadawriter |
1. | shastaflower66 | |
2. | jimneal | |
3. | nevadawriter |
1. | nevadawriter 08/06/2018 Ovid Therapeutics Announces Positive Topline Data from Phase 2 STARS Trial of OV101 for the Treatment of Angelman Syndrome |
2. | shastaflower66 07/12/2018 Ovid Therapeutics Announces Initiation of Phase 2 ROCKET Clinical Trial to Evaluate OV101 in Fragile X Syndrome |
3. | shastaflower66 03/16/2018 Ovid Therapeutics Announces OV101 Granted Fast Track Designation by U.S. FDA for Treatment of Fragile X Syndrome |